Firsthand Technology Value Fund (NASDAQ: SVVC) is a closed-end investment fund that invests in privately held and publicly traded technology and technology-related companies. The fund generates returns primarily through capital appreciation on its venture capital and equity investments, targeting early-stage and small companies with what it characterizes as exceptional growth potential. Investment management is handled by Firsthand Capital Management, Inc., formerly known as SiVest Group, Inc. The fund was incepted on April 18, 2011, and its 10-K for the year ended December 31, 2025 was filed March 30, 2026. As of December 31, 2025, the portfolio included private holdings such as IntraOp Medical Corp. (medical devices), Lyncean Technologies (semiconductor equipment), Revasum (semiconductor equipment), UCT Coatings (advanced materials), and Wrightspeed (electric drivetrains), as well as a position in Fidelity Investments Money Market Treasury Portfolio Class I. Several private holdings carried a fair value of $0 as of December 31, 2025. Kevin Landis serves as Chairman, CEO, and CFO.
Closed-end fund shares traded on a public exchange. Underlying portfolio investments include venture capital positions in private companies across medical devices, semiconductor equipment, advanced materials, and electric drivetrains, plus money market holdings as of December 31, 2025.
Returns are generated through capital appreciation on equity and debt investments in technology-focused companies. The fund may also hold debt securities for income and as a reserve. No distributions were paid in 2025.
Shareholders investing in publicly traded closed-end fund shares. Underlying portfolio companies operate in medical devices, semiconductor equipment, advanced materials, and electric drivetrain end markets.
Portfolio companies are based in California and Florida based on disclosures in the December 31, 2025 10-K filing.
Loading...